How Acute Kidney Injury Is Staged, and Why It Is Not the Same as CKD

Acute kidney injury (AKI) is graded one to three by how far a person's serum creatinine rises above their own baseline and how long their urine output stays low, using thresholds the KDIGO 2012 guideline set out. Chronic kidney disease (CKD) is a different diagnosis: it names changes in kidney structure or function that persist for at least three months, and it is graded by filtration rate and albuminuria rather than by an abrupt jump. The two words share "kidney" and often the same creatinine value on a lab report, yet they sit at opposite ends of a clock. One arrives over hours and is often reversible; the other unfolds over years. That gap in tempo is why clinicians appraise them through separate systems.

Key points#

• AKI is defined by change over hours to days, not by any single creatinine value.
• KDIGO grades AKI in three stages using two signals: serum creatinine and urine output. A patient lands at whichever stage their worst finding reaches.
• CKD requires kidney abnormalities lasting more than three months and is classified by cause, filtration rate (G1 to G5), and albuminuria (A1 to A3).
• One elevated creatinine, read alone, cannot tell you which of the two it represents. Trajectory and history do.

Start with the clock#

The most reliable way to keep AKI and CKD apart is to ask one question first: how long has this been happening? AKI is a story told in hours and days. CKD is a story told in months and years. Almost everything else about how the two are defined and graded follows from that one difference.

This matters because the same creatinine number can mean opposite things. A value of, say, 1.8 mg/dL might be a healthy baseline for one person and a five-alarm signal in another whose kidneys were clearing waste normally last week. The number is not the diagnosis. The movement of the number over time is.

How AKI is defined#

Before 2012, two overlapping frameworks described sudden kidney dysfunction: the RIFLE criteria (2004) and the AKIN criteria (2007), each with slightly different cutoffs and time windows. The mismatch made studies awkward to compare, and the KDIGO 2012 guideline folded them into one definition, now the common reference for both research and bedside use, as later peer-reviewed appraisals of AKI methodology note.

Under KDIGO, AKI is present if any one of three things occurs:

• serum creatinine rises by at least 0.3 mg/dL (26.5 micromol/L) within 48 hours, or
• serum creatinine reaches at least 1.5 times a known or presumed baseline within the prior seven days, or
• urine output falls below 0.5 mL/kg/h for six hours.

Two of the three are tied to a clock on purpose. AKI is defined by change, so the definition insists that you know where the creatinine started and how quickly it moved, not just where it landed.

The three stages#

Once AKI is diagnosed, KDIGO grades severity in three stages. A patient is placed at whichever stage their worst finding reaches, whether that finding is the creatinine or the urine output.

• Stage 1: creatinine 1.5 to 1.9 times baseline, or a rise of at least 0.3 mg/dL; or urine output below 0.5 mL/kg/h for six to twelve hours.
• Stage 2: creatinine 2.0 to 2.9 times baseline; or urine output below 0.5 mL/kg/h for twelve hours or more.
• Stage 3: creatinine 3.0 times baseline or higher, or a rise to at least 4.0 mg/dL, or the start of kidney replacement therapy (dialysis); or urine output below 0.3 mL/kg/h for 24 hours or more, or no urine at all for twelve hours.

One detail is easy to miss: stage 3 can be reached by a decision rather than a number. Starting dialysis defines the most severe stage on its own, because needing that intervention is itself a measure of how far function has dropped.

Why two measures, not one#

The staging system leans on creatinine and urine output together because each tells a different part of the story.

Serum creatinine is a lagging indicator. It reflects the balance between production and clearance, and it takes time to build up after filtration falls. A creatinine that still looks acceptable can understate an injury already in progress, the way a fuel gauge can sit near full for a while after the tank starts draining.

Urine output is closer to a live readout of function, which is why the oliguria thresholds tighten as the stages climb; watching both signals lowers the chance that a slow-rising creatinine hides a kidney that has, in practical terms, already stopped keeping up.

Where CKD sits, and why it is graded apart#

CKD is not a severe version of AKI. It is a separate diagnosis built for the long view: by the KDIGO definition, it requires abnormalities of kidney structure or function present for more than three months, with consequences for health. It is then classified three ways: by cause, by glomerular filtration rate in categories G1 through G5, and by albuminuria in categories A1 through A3. Clinicians often shorthand this as the CGA framework.

Every part of that scheme is designed to estimate risk over years, such as the odds of progression, cardiovascular complications, and the need for long-term planning. It was never meant to capture a swing over a single weekend, which is precisely what AKI staging is for.

Between the two lies a bridge category. Acute kidney disease covers changes that outlast the abrupt AKI window but fall short of the three-month chronic threshold. The relationship also runs both ways: an episode of AKI raises the later risk of CKD, and established CKD leaves the kidneys more vulnerable to a fresh acute insult.

Two questions, two toolkits#

In the end, the two systems exist because they answer different questions.

Staging AKI answers an urgent one: how bad is this right now, and where is it heading over the next hours and days? That framing drives immediate moves such as adjusting fluids, pausing nephrotoxic medications, correcting drug doses for reduced clearance, and deciding whether dialysis is warranted. Because higher stages track with worse short-term outcomes, the grade is a trigger for action on a compressed timeline.

Staging CKD answers a slower one: over the coming months and years, how likely is this person to progress, accumulate cardiovascular risk, and need ongoing management? Its categories are prognostic tools that inform blood-pressure targets, medication choices, and the timing of a specialist referral. The assumptions differ too. AKI is treated as potentially recoverable, so the effort goes toward rescuing function. CKD is treated as durable, so the effort goes toward slowing decline, and if you run one system's logic on the other you would misread the pace of the disease, which is the very mistake the separate frameworks were built to prevent.